Thyroid dysfunction in patients with systemic lupus erythematosus (SLE): relation to disease activity

By Mader Reuven   Mishail Samer   Adawi Muhammed   Lavi Idit   Luboshitzky Rafael  

Clinical Rheumatology, Vol. 26, Iss. 11, 2007-11 ,pp. : 1891-1894

Springer Publishing Company

Access to resources Recommend Favorite

Disease activity and antinucleosome antibodies in systemic lupus erythematosus

By Benucci Maurizio   Benucci Maurizio   Benucci Maurizio   Benucci Maurizio   Benucci Maurizio   Benucci Maurizio  

Scandinavian Journal of Rheumatology, Vol. 32, Iss. 1, 2003-01 ,pp. : 42-45

Informa Healthcare

Access to resources Recommend Favorite

Omega-3 in SLE: a double-blind, placebo-controlled randomized clinical trial of endothelial dysfunction and disease activity in systemic lupus erythematosus

By Bello Kayode   Fang Hong   Fazeli Parastoo   Bolad Waleed   Corretti Mary   Magder Laurence   Petri Michelle  

Rheumatology International, Vol. 33, Iss. 11, 2013-11 ,pp. : 2789-2796

Springer Publishing Company

Access to resources Recommend Favorite

Elevated interleukin-18 levels correlated with disease activity in systemic lupus erythematosus

By Park Min Chan   Park Yong Beom   Lee Soo Kon  

Clinical Rheumatology, Vol. 23, Iss. 3, 2004-06 ,pp. : 225-229

Springer Publishing Company

Access to resources Recommend Favorite

Antimalarials in systemic lupus erythematosus: benefits beyond disease activity

By Andrade Rosa M   Alarcón Graciela S  

Future Rheumatology, Vol. 1, Iss. 2, 2006-04 ,pp. : 225-233

Future Medicine

Access to resources Recommend Favorite